2m 2m 2m 2m 2m 2m 2m
Standard BioTool (LAB)
NASDAQ
$0.71+$0.02 (+2.46%)
Price as of Sep 11, 2026 7:54 PM EDT- $270.9MMarket Cap
- -46.51%1-Year Change
- Medical DevicesIndustry
Standard BioTool (LAB)
$0.71+$0.02 (+2.46%)
LAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.69 | ||
Change | +$0.0003 (+0.04%) | ||
Open | $0.70 | ||
High | $0.70 | ||
Low | $0.68 | ||
Previous Close | $0.69 | ||
Volume | 1,745,577 | ||
30-Day Average Volume | 1,792,196 | ||
1-Week Change | 0.66% | ||
1-Month Change | -12.38% | ||
1-Year Change | -46.51% | ||
3-Year Change | -75.79% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 392.6M | ||
Total Assets | $627.2M | ||
Market Cap | $270.9M | ||
Enterprise Value | $1.2M | ||
Period: QTR TTM FY | |||
Revenue | $14.5M | ||
Net Income | -$26.8M | ||
Free Cash Flow | -$10.7M | ||
EBIT | -$26.7M | ||
EBITDA | -$26.7M | ||
Net Working Capital | $460.1M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 0 | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue